THE NEW HAZLETT CENTER FOR THE PERFORMING ARTS AND ITS AFFILIATED COMPANIES DISCLAIM ALL WARRANTIES, REPRESENTATIONS OR ENDORSEMENTS, EXPRESSED OR IMPLIED, WITH REGARD TO THE DATA, INFORMATION AND MATERIAL INCLUDED IN, OR ACCESSIBLE FROM, THIS WEBSITE OR THE INTERNET, INCLUDING, BUT NOT LIMITED TO, ALL IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT
Semaglutide is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes, administered as a once-weekly subcutaneous injection
Always ensure your experimental design accounts for the distinct receptor selectivity profiles of each compound being studied
Among the 4 DOACs, dabigatran is a direct and competitive thrombin inhibitor, 2 whereas the other 3 are factor Xa inhibitors ( Figure )
Targeting microRNAs in cancer: rationale, strategies and challenges
According to Yale Medicine, these drugs are primarily used for type 2 diabetes management and obesity treatment, and they work best alongside healthy eating and physical activity